A detailed history of Mather Group, Llc. transactions in Laboratory Corp Of America Holdings stock. As of the latest transaction made, Mather Group, Llc. holds 631 shares of LH stock, worth $140,138. This represents 0.0% of its overall portfolio holdings.

Number of Shares
631
Previous 626 0.8%
Holding current value
$140,138
Previous $136,000 5.88%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

BUY
$192.5 - $216.35 $962 - $1,081
5 Added 0.8%
631 $128,000
Q1 2024

Apr 08, 2024

BUY
$209.01 - $232.56 $130,840 - $145,582
626 New
626 $136,000
Q2 2023

Aug 08, 2023

BUY
$211.93 - $241.33 $185,438 - $211,163
875 New
875 $211,000
Q1 2022

May 13, 2022

SELL
$259.82 - $298.18 $169,142 - $194,115
-651 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$271.6 - $314.21 $176,811 - $204,550
651 New
651 $204,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.